Figure 2.

Perceived benefit (A), acceptability (B), likelihood of personal use (C) Perceived invasiveness (D), Risk (E), and change to person (F), by neurotechnology and symptom.

Perceived benefit (A), acceptability (B), likelihood of personal use (C) Perceived invasiveness (D), Risk (E), and change to person (F), by neurotechnology and symptom.